Stocksigma LogoStocksigma Logo

Alkem Laboratories Q2FY27 Results: Revenue Up 13.8% YoY, PAT Down 11.7%

Alkem Laboratories reported consolidated Q2FY27 revenue from operations of ₹45,520 mn, rising 13.8% YoY (up 21.7% QoQ), supported by India sales growth of

Alkem Laboratories Q2FY27 Results: Revenue Up 13.8% YoY, PAT Down 11.7%

Alkem Laboratories Ltd · Financial Result · 12 Nov 2026, 7:25 pm

Alkem Laboratories Q2FY27 Results: Revenue Up 13.8% YoY, PAT Down 11.7% Alkem Laboratories reported consolidated Q2FY27 revenue from operations of ₹45,520 mn, rising 13.8% YoY (up 21.7% QoQ), supported by India sales growth of 9.5% YoY to ₹30,275 mn and international sales expansion of 22.3% YoY to ₹14,540 mn. EBITDA rose 11.3% YoY to ₹10,252 mn, with margins at 22.5% (down 50 bps YoY). Net profit attributable to owners declined 11.7% YoY to ₹6,753 mn due to a higher effective tax rate. The company completed its 55% stake acquisition in Occlutech on 16th Jul'26.

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements